AMICUS THERAPEUTICS, INC. — Director's Dealing 2017

Sep 28, 2017

SEC Form 4/A — Form 4/A

Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2017-09-26

Reporting Person: Crowley John F (Director, Chairman & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-09-26	Common Stock	M	1395	$14.36	Acquired	328001	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-09-26	Stock Options (right to buy)	$3.19	M	1395	Disposed	2024-01-03	Common Stock (1395)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	64895	Indirect